Table 4 Time from presentation to treatment for presenting colorectal cancer symptoms and other clinical variables

From: Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas

  

Days from presentation to treatment-geometric mean (95% CI)

 

N=1071

Number with symptom (%)

With

Without

P-value

Abdominal pain

318 (30)

102 (83–125)

158 (144–173)

<0.001

Palpable abdominal mass

40 (4)

32 (22–48)

147 (134–160)

<0.001

Rectal bleeding

286 (27)

105 (92–120)

153 (137–171)

<0.001

Rectal mass

31 (3)

46 (35–59)

143 (131–157)

<0.001

Guarding

6 (1)

22 (0.9–540)

140 (128–153)

0.003

Nausea

36 (3)

77 (39–153)

141 (129–155)

0.017

Rectal mucus discharge

47 (4)

85 (60–122)

142 (129–155)

0.023

Tenesmus

29 (3)

76 (49–116)

141 (129–154)

0.028

Increased frequency of bowel movements

67 (6)

99 (72–135)

142 (129–156)

0.057

Abdominal distension

60 (6)

98 (57–170)

141 (129–155)

0.066

Vomiting

83 (8)

105 (65–170)

142 (130–155)

0.083

Number of symptoms at presentation

   

<0.001

 0

26 (2)

57 (27–119)

 

 1

459 (43)

208 (184–235)

 

 2

332 (31)

133 (114–156)

 

 3

150 (14)

104 (83–131)

 

 4 or more

104 (10)

49 (36–68)

 

History of anxiety or depression

143 (13)

210 (167–264)

130 (118–143)

<0.001

Past history of benign bowel disease

168 (16)

169 (133–215)

133 (121–147)

0.059

GP consultations/month

   

<0.001

 0–0.5

248 (23)

620 (571–673)

 

 0.5–2.5

247 (23)

182 (164–202)

 

 2.5–10

222 (21)

92 (82–105)

 

 >10

283 (26)

49 (40–59)

 

Tumour site

   

0.072

 Right side colon to hepatic flexure

263 (25)

163 (136–197)

 

 Transverse colon to splenic flexure

105 (10)

102 (73–141)

 

 Descending and sigmoid colon

286 (27)

140 (116–170)

 

 Rectosigmoid and rectum

379 (35)

136 (120–154)

 

 Unspecified or overlapping

38 (4)

111 (66–188)

 
  1. No differences (P>0.10) for rectal or anal discomfort, melaena, breathlessness, pallor, tiredness, anaemia, weight loss, anorexia, unspecified changes in bowel habit, urgency, diarrhoea, constipation, nonspecific anal symptoms, faecal incontinence or discharge, iron medication at time of presentation, or previous benign colorectal investigations.